STEPHEN FROM - 02 Nov 2021 Form 4 Insider Report for EYEGATE PHARMACEUTICALS INC (KPRX)

Role
Executive Chairman, Director
Signature
/s/ Sarah Romano, Attorney-in-Fact*
Issuer symbol
KPRX
Transactions as of
02 Nov 2021
Net transactions value
-$495
Form type
4
Filing time
03 Nov 2021, 16:16:21 UTC
Previous filing
05 Oct 2021
Next filing
08 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Tax liability $495 -250 -0.36% $1.98 68,292 02 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover taxes due on restricted stock that vested on 11/01/2021.